This is a Validated Antibody Database (VAD) review about human PDCD1LG2, based on 19 published articles (read how Labome selects the articles), using PDCD1LG2 antibody in all methods. It is aimed to help Labome visitors find the most suited PDCD1LG2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
PDCD1LG2 synonym: B7DC; Btdc; CD273; PD-L2; PDCD1L2; PDL2; bA574F11.2

BioLegend
mouse monoclonal (24F.10C12)
  • flow cytometry; human; loading ...; fig 3b
BioLegend PDCD1LG2 antibody (BioLegend, 329605) was used in flow cytometry on human samples (fig 3b). Cancers (Basel) (2021) ncbi
mouse monoclonal (24F.10C12)
  • flow cytometry; human; loading ...; fig s3
BioLegend PDCD1LG2 antibody (BioLegend, 329605) was used in flow cytometry on human samples (fig s3). Stem Cell Reports (2020) ncbi
mouse monoclonal (MIH18)
  • flow cytometry; human; loading ...; fig 3b
BioLegend PDCD1LG2 antibody (Biolegend, 345505) was used in flow cytometry on human samples (fig 3b). Cell Rep (2019) ncbi
mouse monoclonal (24F.10C12)
  • flow cytometry; human; 1:300; loading ...; fig 2c
BioLegend PDCD1LG2 antibody (Biolegend, 24F.10C12) was used in flow cytometry on human samples at 1:300 (fig 2c). JCI Insight (2019) ncbi
mouse monoclonal (24F.10C12)
  • flow cytometry; human; loading ...; fig 2d
BioLegend PDCD1LG2 antibody (BioLegend, 24F.10C12) was used in flow cytometry on human samples (fig 2d). Leukemia (2019) ncbi
mouse monoclonal (MIH18)
  • flow cytometry; human; loading ...; fig 1c
BioLegend PDCD1LG2 antibody (BioLegend, MIH18) was used in flow cytometry on human samples (fig 1c). Front Immunol (2018) ncbi
mouse monoclonal (MIH18)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BioLegend PDCD1LG2 antibody (BioLegend, MIH18) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (MIH18)
BioLegend PDCD1LG2 antibody (BioLegend, MIH18) was used . Clin Cancer Res (2014) ncbi
Invitrogen
mouse monoclonal (MIH18)
  • flow cytometry; mouse; 1:250; loading ...; fig 2d
Invitrogen PDCD1LG2 antibody (ThermoFisher, 17-5888-42) was used in flow cytometry on mouse samples at 1:250 (fig 2d). Cancer Res (2021) ncbi
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig 2a
In order to assess the critical role of programmed death protein 1/programmed death-ligand 1 in the polarization of microglia during intracerebral hemorrhage-induced secondary brain injury, Invitrogen PDCD1LG2 antibody (Thermo Fisher, PA5-20344) was used in western blot on rat samples (fig 2a). J Neuroinflammation (2017) ncbi
mouse monoclonal (MIH18)
  • immunohistochemistry - frozen section; human; 1:50; fig 2
In order to investigate factors that regulate delayed-type hypersensitivity, Invitrogen PDCD1LG2 antibody (eBioscience, MIH18) was used in immunohistochemistry - frozen section on human samples at 1:50 (fig 2). F1000Res (2015) ncbi
mouse monoclonal (MIH18)
  • flow cytometry; human
Invitrogen PDCD1LG2 antibody (eBioscience, MIH18) was used in flow cytometry on human samples . PLoS Negl Trop Dis (2014) ncbi
mouse monoclonal (MIH18)
  • western blot; mouse
Invitrogen PDCD1LG2 antibody (eBioscience, MIH18) was used in western blot on mouse samples . Arthritis Rheum (2010) ncbi
Santa Cruz Biotechnology
mouse monoclonal (XX19)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1
Santa Cruz Biotechnology PDCD1LG2 antibody (SantaCruz, sc-80285) was used in immunohistochemistry - paraffin section on human samples (fig 1). Cancer Sci (2016) ncbi
BD Biosciences
mouse monoclonal (MIH18)
  • flow cytometry; human; fig s6i
BD Biosciences PDCD1LG2 antibody (BD Bioscience, MIH18) was used in flow cytometry on human samples (fig s6i). Mol Cancer Ther (2022) ncbi
mouse monoclonal (MIH18)
  • flow cytometry; human; loading ...; fig s5a
BD Biosciences PDCD1LG2 antibody (BD, MIH18) was used in flow cytometry on human samples (fig s5a). JCI Insight (2018) ncbi
mouse monoclonal (MIH18)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences PDCD1LG2 antibody (BD, 558066) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (MIH18)
  • flow cytometry; human; loading ...; fig 3b,e
In order to look at patterns of S. Typhi-specific modulation of the homing potential of circulating Treg in patients with typhoid compared to healthy individuals, BD Biosciences PDCD1LG2 antibody (BD, 563842) was used in flow cytometry on human samples (fig 3b,e). PLoS Pathog (2015) ncbi
mouse monoclonal (MIH18)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, BD Biosciences PDCD1LG2 antibody (BD Pharmingen, clone MIH18) was used in flow cytometry on human samples . Chest (2015) ncbi
Articles Reviewed
  1. Sullivan P, Kumar R, Li W, Hoglund V, Wang L, Zhang Y, et al. FGFR4-Targeted Chimeric Antigen Receptors Combined with Anti-Myeloid Polypharmacy Effectively Treat Orthotopic Rhabdomyosarcoma. Mol Cancer Ther. 2022;21:1608-1621 pubmed publisher
  2. Lavoie R, Gargollo P, Ahmed M, Kim Y, Baer E, Phelps D, et al. Surfaceome Profiling of Rhabdomyosarcoma Reveals B7-H3 as a Mediator of Immune Evasion. Cancers (Basel). 2021;13: pubmed publisher
  3. Kharkwal S, Johndrow C, Veerapen N, Kharkwal H, Saavedra Avila N, Carreño L, et al. Serial Stimulation of Invariant Natural Killer T Cells with Covalently Stabilized Bispecific T-cell Engagers Generates Antitumor Immunity While Avoiding Anergy. Cancer Res. 2021;81:1788-1801 pubmed publisher
  4. Suzuki D, Flahou C, Yoshikawa N, Stirblyte I, Hayashi Y, Sawaguchi A, et al. iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity. Stem Cell Reports. 2020;14:49-59 pubmed publisher
  5. Celis Gutierrez J, Blattmann P, Zhai Y, Jarmuzynski N, Ruminski K, Gregoire C, et al. Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy. Cell Rep. 2019;27:3315-3330.e7 pubmed publisher
  6. Geng Y, Liu X, Liang J, Habiel D, Kulur V, Coelho A, et al. PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis. JCI Insight. 2019;4: pubmed publisher
  7. Kataoka K, Miyoshi H, Sakata S, Dobashi A, Couronné L, Kogure Y, et al. Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas. Leukemia. 2019;: pubmed publisher
  8. Richardson J, Armbruster N, Günter M, Henes J, Autenrieth S. Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells. Front Immunol. 2018;9:2603 pubmed publisher
  9. Liu R, Merola J, Manes T, Qin L, Tietjen G, Lopez Giraldez F, et al. Interferon-γ converts human microvascular pericytes into negative regulators of alloimmunity through induction of indoleamine 2,3-dioxygenase 1. JCI Insight. 2018;3: pubmed publisher
  10. Wu J, Sun L, Li H, Shen H, Zhai W, Yu Z, et al. Roles of programmed death protein 1/programmed death-ligand 1 in secondary brain injury after intracerebral hemorrhage in rats: selective modulation of microglia polarization to anti-inflammatory phenotype. J Neuroinflammation. 2017;14:36 pubmed publisher
  11. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  12. Ogiya R, Niikura N, Kumaki N, Bianchini G, Kitano S, Iwamoto T, et al. Comparison of tumor-infiltrating lymphocytes between primary and metastatic tumors in breast cancer patients. Cancer Sci. 2016;107:1730-1735 pubmed publisher
  13. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  14. Gulati N, Suárez Fariñas M, Correa Da Rosa J, Krueger J. Psoriasis is characterized by deficient negative immune regulation compared to transient delayed-type hypersensitivity reactions. F1000Res. 2015;4:149 pubmed publisher
  15. McArthur M, Fresnay S, Magder L, Darton T, Jones C, Waddington C, et al. Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model. PLoS Pathog. 2015;11:e1004914 pubmed publisher
  16. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed publisher
  17. O Regan N, Steinfelder S, Venugopal G, Rao G, Lucius R, Srikantam A, et al. Brugia malayi microfilariae induce a regulatory monocyte/macrophage phenotype that suppresses innate and adaptive immune responses. PLoS Negl Trop Dis. 2014;8:e3206 pubmed publisher
  18. Taube J, Klein A, Brahmer J, Xu H, Pan X, Kim J, et al. Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy. Clin Cancer Res. 2014;20:5064-74 pubmed publisher
  19. Raptopoulou A, Bertsias G, Makrygiannakis D, Verginis P, Kritikos I, Tzardi M, et al. The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis. Arthritis Rheum. 2010;62:1870-80 pubmed publisher